--- title: "Hongchang International Co. (HCIL) stock and investor profile" url: "https://aibio.space/companies/hongchang-international/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Hongchang International Co., Ltd (OTC: HCIL), United States. Listing facts, related biotech companies and news on aibio.space." --- HCIL Hongchang International Co., Ltd OTC · United States # Hongchang International Co. (HCIL) news Hongchang International Co., Ltd is a public biotech or pharmaceutical company listed on OTC under the ticker HCIL, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Hongchang International Co. news We have not published a story on Hongchang International Co. yet. When there is news, it will appear here. ## Hongchang International Co. at a glance - **Ticker**: HCIL - **Listing**: OTC - **Country**: United States - **Cash, Dec 31, 2025**: $551,778 ### Related companies - [PAVmed](https://aibio.space/companies/pavmed/) NASDAQ: PAVM - [BIOADAPTIVES, INC.](https://aibio.space/companies/bioadaptives/) OTC: BDPT - [Cryoport](https://aibio.space/companies/cryoport/) NASDAQ: CYRX - [Jushi Holdings](https://aibio.space/companies/jushi/) OTC: JUSH - [YD Bio](https://aibio.space/companies/yd-bio/) NASDAQ: YDES - [Research Alliance Corp III](https://aibio.space/companies/research-alliance-iii/) NASDAQ: RACC - [National Vision Holdings](https://aibio.space/companies/national-vision/) NASDAQ: EYE - [Seer](https://aibio.space/companies/seer/) NASDAQ: SEER ### Also on OTC - [Acura Pharmaceuticals](https://aibio.space/companies/acura-pharmaceuticals/) ACUR - [ESCALON MEDICAL CORP](https://aibio.space/companies/escalon-medical/) ESMC - [EHOUSE GLOBAL INC](https://aibio.space/companies/ehouse-global/) EHOS - [Zomedica](https://aibio.space/companies/zomedica/) ZOMDF - [IMV INC](https://aibio.space/companies/imv/) IMVIF - [EAGLE PHARMACEUTICALS INC](https://aibio.space/companies/eagle-pharmaceuticals/) EGRX ## Hongchang International Co. annual financials | Line | FY2024 | FY2023 | |---|---|---| | Revenue | [$2.9 million](https://www.sec.gov/Archives/edgar/data/1086303/000101376225004096/) | [$2.7 million](https://www.sec.gov/Archives/edgar/data/1086303/000101376225004096/) | | Net income (loss) | | [-$378,794](https://www.sec.gov/Archives/edgar/data/1086303/000121390024028792/) | | Cash from operations | [-$7.3 million](https://www.sec.gov/Archives/edgar/data/1086303/000101376225004096/) | [$750,521](https://www.sec.gov/Archives/edgar/data/1086303/000101376225004096/) | | Cash and equivalents | [$240,598](https://www.sec.gov/Archives/edgar/data/1086303/000121390026015896/) | [$895,730](https://www.sec.gov/Archives/edgar/data/1086303/000121390024068246/) | Latest balance sheet, Dec 31, 2025 (10-Q): cash and equivalents $551,778. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Hongchang International Co. What is the ticker symbol of Hongchang International Co.? Hongchang International Co., Ltd trades under the ticker HCIL on OTC. Where is Hongchang International Co. listed? Hongchang International Co., Ltd is listed on OTC. Which country or territory is Hongchang International Co. listed under? Our directory records Hongchang International Co., Ltd under United States. Does aibio.space cover Hongchang International Co.? aibio.space lists Hongchang International Co., Ltd among 2,820 public biotech companies and publishes its news here as stories appear. What was Hongchang International Co.'s revenue last year? $2.9 million for the fiscal year ended Dec 31, 2024, as reported to the SEC. How much cash does Hongchang International Co. have? $551,778 in cash at Dec 31, 2025, per its 10-Q. ## Investor discussion: Hongchang International Co. Members talk about Hongchang International Co. (HCIL). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Hongchang International Co., newest first. Each line links the filing it comes from. 1. 2026-08-13 Distress Told the SEC a periodic report would be filed late. SEC Form NT 10-Q. [Source](https://www.sec.gov/Archives/edgar/data/1086303/000121390026088993/ea0301999-nt10q_hongchang.htm) 2. 2026-06-30 Distress Told the SEC a periodic report would be filed late. SEC Form NT 10-K. [Source](https://www.sec.gov/Archives/edgar/data/1086303/000121390026073385/ea0296469-nt10k_hongchang.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open OTC:HCIL on TradingView](https://www.tradingview.com/symbols/OTC-HCIL/). ## Listing details Hongchang International Co., Ltd is a public biotech or pharmaceutical company listed on OTC under the ticker HCIL, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Hongchang International Co., Ltd - **Ticker**: HCIL - **Listing**: OTC - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/hongchang-international/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Hongchang International Co. (HCIL) stock and investor profile", 2026-10-31, https://aibio.space/companies/hongchang-international/